$Histogenics(OCGN)$COVAXIN has received Emergency Use Authorizations in several countries across the globe with another 60 in process. EUA’s have now been obtained from Mexico, Philippines, Iran, Paraguay, Guatemala, Nicaragua, Guyana, Venezuela, Botswana, Zimbabwe, among several other countries. EUA’s are in process in the USA and several European countries. Pricing for international markets and supplies to govt’s under EUA’s have been established between $15 - 20 / dose.
https://www.bharatbiotech.com/images/press/bharat-biotech-covaxin-capacity-expansion-to-worldwide.pdf
精彩评论